Next Article in Journal
Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery
Previous Article in Journal
LMT2368 (1-(4-Chlorophenyl)-3-(3-fluoro-5-(trifluoromethyl)phenyl)urea) Negatively Regulates Inflammation by Inhibiting NLRP3 Inflammasome Activation
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(10), 1238; https://doi.org/10.3390/pharmaceutics17101238
Action Date Notes Link
article xml file uploaded 23 September 2025 11:47 CEST Original file -
article xml uploaded. 23 September 2025 11:47 CEST Update https://www.mdpi.com/1999-4923/17/10/1238/xml
article pdf uploaded. 23 September 2025 11:47 CEST Version of Record https://www.mdpi.com/1999-4923/17/10/1238/pdf
article supplementary file uploaded. 23 September 2025 11:47 CEST - https://www.mdpi.com/1999-4923/17/10/1238#supplementary
article html file updated 23 September 2025 11:49 CEST Original file https://www.mdpi.com/1999-4923/17/10/1238/html
Back to TopTop